Instrument Inactif

Communiqués Capricor Therapeutics Inc OTC Bulletin Board

Actions

CAPR

US14070B1017

Recherche biotechnologique et médicale

Communiqués

11/09	SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline	NE
09/09	CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Capricor Therapeutics, Inc. (CAPR) Investors to Inquire About a Securities Fraud Class Action by September 28, 2026	NE
09/09	LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation	BU
08/09	CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 28, 2026 Deadline - RGRD Law	AQ
03/09	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
02/09	Capricor Therapeutics, Inc. (CAPR) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit	NE
01/09	CAPRICOR THERAPEUTICS, INC. (CAPR) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Class Action by September 28, 2026	NE
31/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
28/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
28/08	Capricor Therapeutics, Inc. (CAPR) Securities Fraud: Contact Berger Montague To Discuss Your Rights	NE
27/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
24/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
24/08	Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA	AQ
21/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
19/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
17/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
17/08	ATTENTION CAPR INVESTORS: Contact Berger Montague About a Capricor Therapeutics, Inc. Class Action Lawsuit	NE
14/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
13/08	Capricor: Q2 Earnings Snapshot	AQ
13/08	Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update	AQ
13/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
13/08	CAPR INVESTOR NOTICE: RGRD Law Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit	AQ
12/08	CAPR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit	BU
10/08	Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
10/08	Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13	AQ